Protein Structure Prediction Platforms Global Market Report 2026

The protein structure prediction platforms market size has grown rapidly in recent years. It will grow from $1.75 billion in 2025 to $2.02 billion in 2026 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to reliance on experimental methods like x-ray crystallography and nmr spectroscopy, limited computational resources, early adoption of homology modeling techniques, increasing demand for drug discovery, growth of academic research in proteomics.

The protein structure prediction platforms market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2030 at a compound annual growth rate (CAGR) of 15.7%. The growth in the forecast period can be attributed to adoption of advanced ai and ml algorithms, expansion of cloud-based platforms, integration with biopharmaceutical pipelines, rising investment in computational biology, demand for high-throughput protein modeling. Major trends in the forecast period include ai-driven protein structure prediction, cloud-based computational platforms, integration with drug discovery pipelines, real-time molecular modeling, predictive disease research analytics.

The increasing demand for personalized medicine is expected to propel the growth of the protein structure prediction platforms market. Personalized medicine customizes healthcare and therapies based on a patient’s distinct biological and personal characteristics. Its adoption is rising due to advancements in genomic technologies, which allow healthcare providers to quickly and accurately analyze genetic information, enabling more precise and effective treatments. Protein structure prediction platforms facilitate personalized medicine in research and drug development by modeling patient-specific protein variants, understanding mutation-driven structural changes, and designing targeted therapies for genetically defined patient groups. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the U.S. Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, compared to six in 2022. Hence, the growing demand for personalized medicine is driving the growth of the protein structure prediction platforms market.

Key companies operating in the protein structure prediction platforms market are focusing on developing innovative solutions, such as structure-based computational biology technologies to accelerate drug discovery, enable accurate protein modeling, and enhance target identification through advanced molecular simulations and AI-driven structural analysis. These systems leverage three-dimensional protein structure data, molecular modeling, and simulation algorithms to analyze biomolecular interactions and support rational drug design. For example, in March 2024, Basecamp Research, a UK-based AI-driven biotechnology company, launched BaseFold, a deep learning model designed to improve 3D protein structure prediction for large and complex proteins. By augmenting AlphaFold2 with its proprietary BaseGraph dataset derived from global biodiversity sources, BaseFold demonstrated up to six-fold improvements in predictive accuracy and three-fold enhancements in small-molecule docking performance in internal benchmarks. Such advances underpin next-generation protein structure prediction platforms by improving the modeling of protein classes that have been underrepresented in public datasets, thereby supporting AI-driven drug discovery efforts.

In October 2025, Eli Lilly and Company, a US-based pharmaceutical company, partnered with NVIDIA Corporation to develop an AI-powered supercomputing platform aimed at advancing protein structure prediction and structure-based drug discovery. The collaboration leverages NVIDIA’s accelerated computing and generative AI technologies to enable large-scale 3D protein modeling, molecular simulations, and protein-ligand interaction analysis. Through this partnership, the companies aim to improve target identification, optimize lead discovery, and accelerate novel therapeutics development by enhancing the accuracy and speed of AI-driven structural biology workflows. NVIDIA Corporation is a US-based technology company specializing in accelerated computing and artificial intelligence solutions.

Major companies operating in the protein structure prediction platforms market are IBM Corporation, Thermo Fisher Scientific Inc., Dassault Systèmes SE, Charles River Laboratories International Inc., Bruker Corporation, Revvity Inc., DeepMind Technologies Limited, Schrödinger Inc., BenevolentAI Limited, Nimbus Therapeutics Inc., Arzeda Corporation, Relay Therapeutics Inc., LabVantage Solutions Inc., Genesis Therapeutics Inc., Bioinformatics Solutions Inc., Chemical Computing Group ULC, Insilico Medicine Inc., Cloud Pharmaceuticals Inc., Peptone Ltd., Molecular Forecaster Inc., Acellera Ltd., CD BioSciences, and ProteinLab.ai Inc.

North America was the largest region in the protein structure prediction platforms market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the protein structure prediction platforms market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the protein structure prediction platforms market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The protein structure prediction platforms market includes revenues earned by entities by providing services such as 3D protein structure modeling, homology modeling and template-based modeling, and protein-protein interaction analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Protein structure prediction platforms are computational tools that use advanced algorithms, machine learning, and bioinformatics to forecast the three-dimensional (3D) structures of proteins based on their amino acid sequences. They accelerate drug discovery, improve understanding of protein function, and reduce dependence on labor-intensive experimental methods like X-ray crystallography and NMR spectroscopy.

The essential components of protein structure prediction platforms include software and services. Software leverages computational methods to predict three-dimensional protein structures, aiding research and drug discovery. Technologies include AI-based methods, homology modeling, ab initio approaches, threading, and hybrid methods, deployed via cloud-based and on-premises models. Applications cover drug discovery, disease research, academic research, biotechnology, and others, serving pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations, and other end users.

Tariffs have influenced the protein structure prediction platforms market by increasing costs for importing specialized software, computational hardware, and data management tools. This impact is most notable in software and services segments, particularly in regions such as North America and Europe that rely on advanced imported technologies. While tariffs have caused short-term cost challenges, they are also encouraging domestic software development and local computational service providers, fostering innovation and regional market growth.

The protein structure prediction platforms market research report is one of a series of new reports that provides protein structure prediction platforms market statistics, including protein structure prediction platforms industry global market size, regional shares, competitors with a protein structure prediction platforms market share, detailed protein structure prediction platforms market segments, market trends and opportunities, and any further data you may need to thrive in the protein structure prediction platforms industry. This protein structure prediction platforms market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.